Streetbeat News

Products Services

IOVA

Recent options trading activity in Iovance Biotherapeutics (NASDAQ:IOVA) indicates a bearish stance by big-money investors, with a split sentiment of 37% bullish and 62% bearish. The options scanner revealed 8 unusual trades, with a price target window from $7.5 to $30.0. Analysts have issued ratings with a consensus target price of $24.6, despite the stock's slight decline and potential overbought status. The company is preparing for potential U.S. regulatory approvals and commercialization of its tumor-infiltrating lymphocyte therapies.

Portfolio Pulse from Benzinga Insights

March 13, 2024 | 4:16 pm

HSY

MDLZ

The global chocolate crisis is worsening as African cocoa plants report running out of beans, according to Reuters News. This situation could potentially impact major chocolate manufacturers and their supply chains.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 4:04 pm

NVDA

ORCL

QQQ

TSLA

The article discusses the impact of AI frenzy and gamma squeeze on the stock market, overpowering concerns about inflation. It highlights the strong performance of Invesco QQQ Trust Series 1 (QQQ) and NVIDIA Corp (NVDA) due to Oracle Corp's (ORCL) earnings indicating high demand for NVIDIA chips. It also notes the mixed money flows in major tech stocks and ETFs, and the momo crowd's shift from Tesla Inc (TSLA) to NVDA. Additionally, it mentions the positive outlook for oil based on API crude inventory data.

Portfolio Pulse from The Arora Report

March 13, 2024 | 3:44 pm

PLTR

On CNBC, Palantir Technologies CEO Alex Karp discussed the company's new Titan deal and its initiative on AI bootcamps, highlighting strategic moves to bolster its position in the AI and data analytics sector.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 3:43 pm

COIN

Block, Inc. (NYSE:SQ) shares rose after announcing new merchant partnerships for Afterpay and the start of shipping for its Bitkey hardware device. The Bitkey wallet, which integrates with Cash App and Coinbase Global, Inc. (NASDAQ:COIN), allows users to transfer and buy Bitcoin. Afterpay expanded its merchant network with notable partnerships. Block's stock is trading above its 200-day moving average, indicating a bullish signal for investors.

Portfolio Pulse from Erica Kollmann

March 13, 2024 | 3:41 pm

GOOG

GOOGL

Waymo, a subsidiary of Alphabet Inc., announced that starting March 14, its fully autonomous ride-hailing service will be available to select members of the public in Los Angeles, as reported by Reuters citing a blog post.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 3:40 pm

PYPL

PayPal Holdings Inc (NASDAQ:PYPL) stock is on the rise, up 5% during midday trading, following the announcement of Aaron J. Webster joining as chief enterprise services officer and a strategic meeting hosted by JPMorgan. The company is focusing on high-margin strategies, including improving transaction margin dollar growth and launching the Fastlane initiative for online checkouts. Additionally, PayPal plans to expand into offline payment channels and monetize Venmo through enhanced debit card penetration and targeted rewards. Shares were up 4.09% to $62.98.

Portfolio Pulse from Surbhi Jain

March 13, 2024 | 3:37 pm

AMZN

GOOG

GOOGL

MSFT

NVDA

ORCL

Oracle Corporation (NYSE:ORCL) has transitioned into a significant cloud computing player, with its cloud revenue surpassing software licensing sales in the fiscal third quarter, causing a 13% stock surge. Despite holding less than 5% of the global cloud market, Oracle competes by offering affordable alternatives to Amazon, Microsoft, and Alphabet. A potential game-changing deal with Nvidia Corporation (NASDAQ:NVDA) is expected to be announced, aiming to power the AI revolution. Oracle's fiscal third quarter saw a 7% revenue increase to $13.28 billion, with cloud services driving growth. However, other units like cloud license and hardware saw declines. Oracle's net income rose 27% YoY to $2.4 billion. The company is expanding its cloud data capacity to meet AI demand, with plans to build 20 data centers from Microsoft and Azure.

Portfolio Pulse from Upwallstreet

March 13, 2024 | 3:34 pm

CMPS

CYBN

MNMD

Cybin Inc. (NYSE:CYBN) received FDA Breakthrough Therapy designation for CYB003, a psilocybin analog for Major Depressive Disorder (MDD), following positive Phase 2 results. This marks a significant step in psychedelic-based treatments for mental health, alongside similar designations for MindMed's LSD-derived treatment and Compass Pathways' psilocybin therapy. Cybin also announced a $150M private placement to fund Phase 3 development of CYB003.

Portfolio Pulse from Lara Goldstein

March 13, 2024 | 3:33 pm

GOOG

GOOGL

MSFT

Alphabet Inc's Google faces criticism for its AI system, Gemini, due to quality issues and biases. The launch was rushed to compete with OpenAI's ChatGPT, leading to controversies, including racially inaccurate image generations. Google has since suspended its image generating software and limited its chatbot from generating answers related to global elections this year. Critics argue Gemini and similar AI could influence user opinions and biases, raising concerns about AI's role in shaping thoughts and democracy.

Portfolio Pulse from Natan Ponieman

March 13, 2024 | 3:21 pm